Chi Podcasts

PEGS Boston 2017 | The Promise of Neoantigens for Personalized Cancer Vaccines

Informações:

Sinopse

Philip Arlen from Precision Biologics recently spoke with CHI. He will be speaking at PEGS in the Adoptive T Cell Therapy conference on May 3rd 2017. Precision Biologics is working with cancer vaccines to develop personalized cancer treatments that target tumors without damaging healthy human tissues. For more information, please visit http://www.PEGSummit.com/TCellTherapy/